FY2024 Earnings Estimate for BioRem Issued By Cormark

BioRem Inc. (CVE:BRM) – Investment analysts at Cormark issued their FY2024 earnings estimates for shares of BioRem in a research note issued to investors on Tuesday, December 17th. Cormark analyst N. Boychuk anticipates that the company will earn $0.19 per share for the year. Cormark currently has a “Moderate Buy” rating on the stock. Cormark also issued estimates for BioRem’s FY2025 earnings at $0.22 EPS and FY2026 earnings at $0.29 EPS.

BioRem Stock Up 6.4 %

Shares of BioRem stock opened at C$3.14 on Friday. The company has a market capitalization of C$49.30 million, a P/E ratio of 14.95 and a beta of 0.85. The company has a debt-to-equity ratio of 48.97, a current ratio of 1.57 and a quick ratio of 1.08. The business has a 50-day moving average of C$2.85 and a two-hundred day moving average of C$2.42. BioRem has a 1 year low of C$0.95 and a 1 year high of C$3.39.

Insider Activity at BioRem

In related news, Director Derek Webb sold 120,000 shares of the firm’s stock in a transaction on Monday, December 2nd. The shares were sold at an average price of C$2.93, for a total transaction of C$351,600.00. 1.90% of the stock is owned by insiders.

About BioRem

BioRem Inc, a clean technology engineering company, designs, manufactures, distributes, and sells air pollution control systems that are used to eliminate odors, volatile organic compounds (VOCs), and hazardous air pollutants (HAPs). It offers biofilters for the removal of odors, H2S, VOCs, and HAPs; and biotrickling filters for applications of high levels of H2S or other water-soluble VOCs.